LIVE MARKET TRACKER :   BSE SENSEX   31698.55      |    NSE NIFTY 9884.75    
GLOBAL MARKETS :  NASDAQ 6426.922   +0.066%    |    FSI London 7310.64   +0.64%    |    NIKKEI Japan 20383.00   +0.43%
  USD GBP EUR CAD AUD INR
USD - 0.7390 0.8381 1.2332 1.2565 64.7750
GBP 1.3533 - 1.1340 1.6687 1.7002 87.6574
EUR 1.1935 0.8821 - 1.4717 1.4995 77.3103
CAD 0.8112 0.5999 0.6798 - 1.0194 52.5590
AUD 0.7961 0.5884 0.6671 0.9816 - 51.5620
INR 0.0154 0.0114 0.0129 0.0191 0.0194 -
Indian-Commodity  :  Equity & Shares  :  Wockhardt gains on receiving final approval from USFDA for Olopatadine HCI

Wockhardt gains on receiving final approval from USFDA for Olopatadine HCI (04-Jul-2017)

Wockhardt is currently trading at Rs. 609.75, up by 4.70 points or 0.78% from its previous closing of Rs. 605.05 on the BSE.

The scrip opened at Rs. 614.90 and has touched a high and low of Rs. 615.30 and Rs. 609.00 respectively. So far 21,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1129.00 on 21-Jul-2016 and a 52 week low of Rs. 555.00 on 22-Jun-2017.

Last one week high and low of the scrip stood at Rs. 615.30 and Rs. 579.80 respectively. The current market cap of the company is Rs. 6,732.00 crore.

The promoters holding in the company stood at 74.25%, while Institutions and Non-Institutions held 7.26% and 18.49% respectively.

Wockhardt has received final approval from United States Food and Drug Administration (USFDA) for its ANDA for 0.1% ophthalmic solution of Olopatadine HCI. The eye drop Olopatadine HCI 0.1% ophthalmic solution is a generic version of Patanol, marketed at US by Alcon, a subsidiary of Novartis.

The product will be manufactured at USFDA approved contract manufacturing organization based in Montreal, Canada.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API's, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.



Top News Today
Zydus Cadila, Oberoi Realty and Artefact Projects to see some action today
(25-Sep-2017)

Zydus Cadila, Oberoi Realty and Artefact Projects to see some action todayZydus Cadila has received the final approval from the USFDA to market Amlodipine and Olmesartan Medoxomil Tablets in strengths of 5 mg/20 mg, 5 mg/40 mg 10 mg/20 mg, and 10 mg/40 mg. The drug is indicated......click on news to read complete article.

REC gets nod to raise Rs 65,000 crore via bonds
(23-Sep-2017)

REC gets nod to raise Rs 65,000 crore via bondsRural Electrification Corporation (REC) has received shareholders' approval to raise up to Rs 65,000 crore via bonds over the next one year. The special resolution was passed at the company's annual general......click on news to read complete article.

BNP Paribas Arbitrage sells 1.40 lakh shares of Matrimony.com
(23-Sep-2017)

BNP Paribas Arbitrage sells 1.40 lakh shares of Matrimony.comBNP Paribas Arbitrage has sold 1.40 lakh shares of Matrimony.com. The fund house has offloaded the same at Rs 817.73 on the NSE on September 22, 2017.Recently, BNP Paribas Arbitrage has offloaded 1,34,102......click on news to read complete article.

International Stock News
US markets end flat on geopolitical concerns
(23-Sep-2017)

US markets end flat on geopolitical concernsThe US markets ended the lackluster session near their neutral lines on Friday on geopolitical concerns amid an escalating war of words between North Korean leader Kim Jong Un and President Donald Trump.......click on news to read complete article.

Asian markets trade lower on heightened geopolitical tensions
(22-Sep-2017)

Asian markets trade lower on heightened geopolitical tensionsThe Asian markets are showing a weak trend on Friday, on renewed geopolitical worries after a report that North Korea could respond to fresh sanctions with a hydrogen bomb in the Pacific. A news report......click on news to read complete article.

US markets closed lower; Dow snaps nine-day winning streak
(22-Sep-2017)

US markets closed lower; Dow snaps nine-day winning streakThe US markets closed lower on Thursday, with the Dow snapping a nine-day winning streak as investors found few reasons to chase equities a day after the Federal Reserve indicated it still intends to deliver......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.